Heart Disease

Heart disease is the number one cause of death for both men and women in the United States, claiming approximately 1 million lives annually. It is expected that by 2020 heart disease will be the leading cause of death throughout the world. 

With such a dismal scenario, the discovery of this new wonder drug, Alirocumab, is invigorating news for high cholesterol patients around the world. Commenting on the findings Dr. Jennifer Robinson, who led the study, said "This is an agent that is doing what we want it to do, it’s very encouraging."  The drug is expected to be in the market in the coming year.

(Photo credit: Wikipedia)

Related articles

• Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
• ODYSSEY COMBO II - Investigational agent outshines ezetimibe for lowering cholesterol
• Amgen seeks U.S. approval of new cholesterol-fighting drug